PNC Financial Services Group
EVOK

PNC Financial Services Group’s Evoke Pharma EVOK Stock Holding History

PNC Financial Services Group’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed -$86 – 4727
2022
Q4 		$86 Buy
+3
New +$66 ﹤0.01% 4703
2018
Q4 		– Sell
-191
Closed -$82K – 4075
2018
Q3 		$82K Hold
191
– – ﹤0.01% 2713
2018
Q2 		$69K Hold
191
– – ﹤0.01% 2776
2018
Q1 		$57K Buy
191
+104
+120% +$34.2K ﹤0.01% 2878
2017
Q4 		$28K Sell
87
-38
-30% -$15.8K ﹤0.01% 3230
2017
Q3 		$60K Hold
125
– – ﹤0.01% 2824
2017
Q2 		$46K Hold
125
– – ﹤0.01% 2942
2017
Q1 		$56K Buy
+125
New +$51.2K ﹤0.01% 2828

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $770M AUM 18.25% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PNC Financial Services Group's EVOK Position: Q1 2023 in Review

PNC Financial Services Group sold out of Evoke Pharma (EVOK) in Q1 2023, closing a stake of 3 shares — an estimated $86 sold.

PNC Financial Services Group first reported a position in EVOK in Q1 2017 and held it in 8 quarters. The position peaked at $82K in Q3 2018. 11 funds tracked by Wall St. Rank hold EVOK as of Q1 2023.

  • PNC Financial Services Group reported no remaining Evoke Pharma position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 3 Evoke Pharma shares in Q1 2023, an estimated $86.
  • PNC Financial Services Group first reported a position in Evoke Pharma in Q1 2017 and held it in 8 quarters.
  • PNC Financial Services Group's Evoke Pharma position peaked at $82K in Q3 2018.
  • 11 funds tracked by Wall St. Rank held Evoke Pharma as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.